Head-to-head · free
Vail Resorts, Inc. vs The Precision Peptide Company
MTN vs PNGAF — return on capital, cash generation, margins and balance sheet side by side.
MTN
0 / 0
measures where MTN leads
PNGAF
0 / 0
measures where PNGAF leads
A simple count of which company scores better on each measure — not a recommendation to buy or sell.
| Measure | MTN · FY2026 | PNGAF |
|---|---|---|
| Revenue | $2.8B | — |
| Net income | $147.5M | — |
| Revenue growth (yearly, multi-year) | 3.0% | — |
| Free cash flow | — | — |
| Free cash flow margin | — | — |
| Net cash / (debt) | — | — |
| ROIC | 7.7% | — |
| Return on equity | 44.4% | — |
| Gross margin | 41.3% | — |
| Operating margin | 15.3% | — |
| Net debt / EBITDA | 4.07x | — |
Figures are as reported by each company; latest fiscal year shown.
Where Vail Resorts, Inc.'s cash went (FY2026)
- Capital spending
- —
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Ask which business is stronger
"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.
Compare them free